| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc Common Stock (DE) | $1.3b | $23.06 | -4.9% | 225.3K | |
| Arbutus Biopharma Corporation Common Stock | $0.8b | $4.20 | -1.2% | 8.0M | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $76.1m | $0.93 | +2.0% | 486.8K | |
| Clene Inc. Common Stock | $56.8m | $5.95 | -3.3% | 54.6K | |
| Zentek Ltd. Common Stock | $55.4m | $0.49 | +1.9% | 71.4K | |
| Lexaria Bioscience Corp. Common Stock | $19.4m | $0.96 | +1.5% | 84.4K | |
| NanoViricides Inc. | $18.8m | $1.26 | -3.1% | 179.5K | |
| Polyrizon Ltd. Ordinary Shares | $12.4m | $14.94 | +1.0% | 64.0K | |
| TransCode Therapeutics, Inc. Common Stock | $7.9m | $8.50 | -2.0% | 1.2K | |
| Aspire Biopharma Holdings, Inc. Common Stock | $4.8m | $0.20 | -6.5% | 4.9M |